NECTAR Study: Nectar (Honey) Effects on Comfort, Thoughts, and Regularity
NECTAR
1 other identifier
interventional
66
1 country
1
Brief Summary
This study aims to test the central hypothesis that adding to the diet daily yogurt with honey provides beneficial effects on digestive health and subjective mood in healthy adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2019
CompletedFirst Posted
Study publicly available on registry
December 5, 2019
CompletedStudy Start
First participant enrolled
May 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2022
CompletedJuly 21, 2023
July 1, 2023
1.5 years
October 2, 2019
July 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intestinal transit time measured using colored dye markers
Determine the impact of consumption of daily yogurt with honey on intestinal transit time in vivo compared to control, yogurt containing heat-inactivated B.lactis with added sugar. Intestinal transit time will be measured using colored dye markers.
2 weeks
Secondary Outcomes (10)
Digestive health measured using daily stool records with the Bristol Stool Scale
2 weeks
Digestive health measured using rating scales of additional symptoms in daily stool records
2 weeks
Digestive health measured using the Gastrointestinal Tolerability questionnaire
2 weeks
Digestive health measured using the Gastrointestinal Quality of Life Index (GIQLI) questionnaire
2 weeks
Mood measured using the Emotional Image Task
2 weeks
- +5 more secondary outcomes
Study Arms (2)
Yogurt with inactivated B. lactis and added cane sugar
PLACEBO COMPARATORParticipants will consume yogurt with heat inactivated B. lactis and added cane sugar twice daily for 14 days.
Yogurt with B. lactis and added honey
EXPERIMENTALParticipants will consume yogurt with B. lactis and added honey twice daily for 14 days.
Interventions
The intervention condition will utilize a commercially available yogurt (Activia) that contains Bifidobacterium animalis lactis DN-173 010/CNCM I-2494 (B. lactis). Participants will consume 170 g of yogurt with honey twice daily for 14 days.
The control condition will utilize a commercially available yogurt (Activia) following heat inactivation of the probiotic Bifidobacterium animalis lactis DN-173 010/CNCM I-2494 (B. lactis). Participants will consume 170 g of the heat-inactivated yogurt with added cane sugar twice daily for 14 days.The added cane sugar will be an isocaloric amount to the honey.
Eligibility Criteria
You may qualify if:
- Males and females
- Between the ages of 22-64 years at the time of consent
- Body mass index of 18.5 to 29.9 kg/m\^2.
- Normal or corrected-to-normal vision based on the minimal 20/20 standard in order to complete the cognitive task (below 20/20 vision).
- Ability to drop off fecal sample within 30 minutes of defecation
- Have between 3-6 bowel movements per week
You may not qualify if:
- Current pregnancy, lactation, or post-menopausal
- Tobacco use
- Honey allergy or intolerance
- Dairy allergy, lactose intolerance
- Food dye allergy/intolerance
- Prior physician diagnosed gastrointestinal disease (chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers, hepatitis, or gastroesophageal reflux disease (GERD))
- Current use or use of antibiotics in the past 3 months
- Current use of any of the following types of medications: laxatives, anti-diarrhea medications, narcotics, enemas, antispasmodics, anticonvulsants, prescription proton pump inhibitors, prokinetic agents, histamine-2 Rc antagonists (prescription GERD medication)
- Body mass index \> 29.9 kg/m\^2
- Prior malabsorptive bariatric surgery (i.e. gastric bypass, sleeve gastrectomy)
- Restrictive bariatric surgery (i.e. adjustable gastric band) within the past 5 years
- Concurrent enrollment in another dietary, exercise, or medication study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Illinois at Urbana-Champaignlead
- National Honey Boardcollaborator
Study Sites (1)
University of Illinois at Urbana-Champaign
Urbana, Illinois, 61801, United States
Related Publications (1)
Mysonhimer AR, Brown MD, Alvarado DA, Cornman E, Esmail M, Abdiel T, Gutierrez K, Vasquez J, Cannavale CN, Miller MJ, Khan NA, Holscher HD. Honey Added to Yogurt with Bifidobacterium animalis subsp. lactis DN-173 010/CNCM I-2494 Supports Probiotic Enrichment but Does Not Reduce Intestinal Transit Time in Healthy Adults: A Randomized, Controlled, Crossover Trial. J Nutr. 2024 Aug;154(8):2396-2410. doi: 10.1016/j.tjnut.2024.05.028. Epub 2024 Jun 1.
PMID: 38830472DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will be blinded to the order in which they receive the study treatments.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2019
First Posted
December 5, 2019
Study Start
May 19, 2021
Primary Completion
November 2, 2022
Study Completion
November 2, 2022
Last Updated
July 21, 2023
Record last verified: 2023-07